Antidepressants not linked to worse early outcomes after traumatic brain injury

Taking certain antidepressants at the time of a traumatic brain injury (TBI) is not associated with an increased risk of ...
Cure Today

Antidepressants May Boost Antitumor Immunity

SSRIs enhance CD8 T cell antitumor activity by inhibiting SERT, an immune checkpoint in tumors, suggesting potential repurposing for cancer immunotherapy. High intratumoral SERT levels correlate with ...
pharmaphorum

Otsuka preps for July decision on centanafadine for ADHD

The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder ...

Otsuka Announces FDA Acceptance and Priority Review of New Drug Application for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that the U.S. Food and Drug Administration (FDA) has accepted for priority ...
Case Western Reserve University

Med's Awais Aftab talks about selective serotonin reuptake inhibitors, SSRIs

Science News: Awais Aftab, clinical assistant professor of psychiatry at the School of Medicine, explained how selective serotonin reuptake inhibitors or SSRIs are not considered addictive. “They ...